Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 27, 2025 Off

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

By GlobeNewswire

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…

December 27, 2025 Off

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

By GlobeNewswire

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) — Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products,…

December 27, 2025 Off

Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction

By GlobeNewswire

RAMAT GAN, Israel, Dec. 26, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company…

December 25, 2025 Off

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

By GlobeNewswire

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) — XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today…

December 25, 2025 Off

ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

By GlobeNewswire

PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures…

December 25, 2025 Off

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth

By GlobeNewswire

Vancouver, Canada, Dec. 24, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a…

December 25, 2025 Off

S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody’s Ratings Agency Revises Outlook to Positive

By GlobeNewswire

The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody’s affirmed Teva’s…

December 25, 2025 Off

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

By GlobeNewswire

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…

December 25, 2025 Off

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

By GlobeNewswire

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) —…

December 25, 2025 Off

DXS International plc (AQSE: DXSP) Update on Cyber Security Incident

By GlobeNewswire

24 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Update on Cyber Security Incident The Board of DXS International plc (“the…

Posts pagination

Previous 1 … 27 28 29 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine